N-Acetylcysteine + Acebrophylline Suppliers & Bulk Manufacturers
Available Forms: Tablets, capsules, syrup
Available Strengths: Capsules 7 Tab: N-Acetylcysteine(600 mg) + Acebrophylline(100 mg); Syrup: 100 mg+ 50 mg
Reference Brands: Respiract, Ascoril LS-AX, Acebryl-N, Nacbro, Brio-Nac(India & others)
Category:
Respiratory Disorder
N-Acetylcysteine + Acebrophylline is a dual-action respiratory medicine used for treating COPD, chronic bronchitis, and mucus-related lung conditions. It combines a mucolytic (NAC) with a bronchodilator (Acebrophylline) to reduce mucus, ease breathing, and improve lung function. Widely prescribed in India and exported globally.
N-acetylcysteine + acebrophylline is available in Tablets, capsules, syrup
and strengths such as Capsules 7 Tab: N-Acetylcysteine(600 mg) + Acebrophylline(100 mg); Syrup: 100 mg+ 50 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, N-acetylcysteine + acebrophylline is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
N-acetylcysteine + acebrophylline can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
N-Acetylcysteine + Acebrophylline is a powerful respiratory drug combination used to manage COPD, chronic bronchitis, and other mucus-related respiratory disorders. N-Acetylcysteine acts as a potent mucolytic and antioxidant, breaking down thick mucus and supporting lung detoxification, while Acebrophylline functions as a bronchodilator and anti-inflammatory agent, easing airway obstruction and improving breathing. This dual-action therapy enhances respiratory function, reduces cough and congestion, and improves patient comfort. Commonly available in 600 mg + 100 mg strength (capsule or tablet form), it is widely prescribed in India and exported globally. Ideal for chronic respiratory care, this combo is a top B2B pharmaceutical product.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing